JOB vs CCRN vs KELYA vs TBI vs MAN

For growth investors, TrueBlue, Inc.

(TBI) is the stronger pick with 3. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Cross Country Healthcare, Inc.

(CCRN) delivered a total return of -23. 8%, compared to -76. 4% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: CCRN returned -7. 9% versus JOB's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), GEE Group, Inc.

(JOB) is the lower-risk stock at 0. 64β versus Kelly Services, Inc. 's 0. 92β — meaning KELYA is approximately 44% more volatile than JOB relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), TrueBlue, Inc.

(TBI) is pulling ahead at 3. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, MAN leads at -3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ManpowerGroup Inc.

(MAN) is the more profitable company, earning -0. 1% net margin versus -36. 0% for GEE Group, Inc. — meaning it keeps -0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAN leads at 1. 3% versus -2. 9% for JOB. At the gross margin level — before operating expenses — JOB leads at 33. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ManpowerGroup Inc.

(MAN) trades at 9. 2x forward P/E versus 142. 4x for Cross Country Healthcare, Inc. — 133. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 24. 6% to $15. 00.

In this comparison, MAN (4.

2% yield), KELYA (2. 6% yield) pay a dividend. JOB, CCRN, TBI do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, ManpowerGroup Inc.

(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 69), 4. 2% yield). Both have compounded well over 10 years (MAN: -24. 5%, TBI: -64. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (JOB (Industrials) and CCRN (Healthcare) and KELYA (Industrials) and TBI (Industrials) and MAN (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: JOB is a small-cap quality compounder stock; CCRN is a small-cap quality compounder stock; KELYA is a small-cap quality compounder stock; TBI is a small-cap quality compounder stock; MAN is a small-cap income-oriented stock. KELYA, MAN pay a dividend while JOB, CCRN, TBI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.